mmu-mir-107: Mmu-mir-107 is a murine miRNA that is involved in the regulation of various pathways, including the MAPK and FOXO pathways [PMC6833270]. It is one of the differentially expressed (DE) miRNAs that play a role in the regulation of PTGs in these pathways [PMC6833270]. Mmu-mir-107 is also one of the DE miRNAs with the highest degree in the network, indicating its importance in these pathways [PMC6833270]. Additionally, mmu-mir-107 has been found to have similar roles as mmu-miR-103 and mmu-miR-181a in regulating insulin sensitivity and promoting metastasis of colorectal cancer [PMC3937077]. Mmu-mir-107 shares its name with hsa-mir-107, a human miRNA, indicating orthology between these two species [PMC3731538]. In a study on DIO mice, mmu-mir-107 was found to be downregulated in DIO mice compared to DIO + LFD mice [PMC4571067]. Mmu-mir-107 has also been used as a target for qRT-PCR analysis using specific kits [PMC7847849]. Furthermore, LNA probes have been used to detect mmu-mir-107 expression [PMC4860119]. In Alzheimer's disease (AD), mmu-mir-107 has been found to be downregulated and involved in regulating BACE1 expression and disease progression [PMC6906698].